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109-116, 1984.-As part of the American Medical Research 
Expedition to Everest in 1981, we measured hemoglobin con- 
centration, red cell 2,3-diphosphoglycerate (2,3-DPG), Pop at 
which hemoglobin is 50% saturated (P&, and acid-base status 
in expedition members at various altitudes. All measurements 
were made in expedition laboratories and, with the exception 
of samples from the South Co1 of Mt. Everest (8,050 m), within 
2 h of blood collection. In vivo conditions were estimated from 
direct measurements of arterial blood gases and pH or inferred 
from base excess and alveolar Pco~. As expected, increased 2,3- 
DPG was associated with slightly increased PsO, when expressed 
at pH 7.4. Because of respiratory alkalosis, however, the sub- 
jects’ in vivo P 5. at 6,300 m (27.6 Torr) was slightly less than 
at sea level (28.1 Torr). The estimated in vivo Pso was progres- 
sively lower at 8,050 m (24.9 Torr) and on the summit at 8,848 
m (19.4 Torr in one subject). Our data suggest that, at extreme 
altitude, the blood O2 equilibrium curve shifts progressively 
leftward because of respiratory alkalosis. This left shift protects 
arterial O2 saturation at extreme altitude. 
high altitude; acid-base; oxygen affinity; hemoglobin; 2,3-di- 
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THE ERYTHROPOIETIC SYSTEM can participate in adap- 
tation to high altitude in at least two ways: increased red 
cell number, and shifts in the position of the hemoglobin- 
02 equilibrium curve (OEC). The latter is controlled 
mainly by H+ (the Bohr effect) and 2,3-diphosphoglyc- 
erate (2,3-DPG). COz is an additional effector, but its 
physiologic importance under extreme conditions is less 
well defined. 
A modest increase in the red cell mass is useful, phys- 
iologically, in increasing the 02 carrying capacity of the 
blood (6). However, recent speculation has cast doubt 
about the quantitative benefit from this mechanism. 
Since increasing hematocrit leads to an exponential in- 
crease in blood viscosity, systemic and pulmonary pres- 
sures and resistance to flow could be undesirable conse- 
quences (8). 
Whether a shift to the right or left of the OEC could 
be beneficial in hypoxia is another dilemma needing 
experimental clarification. Theoretical and animal stud- 
ies (5, 22) suggest that a left shift would be beneficial at 
extreme altitude, but few data in humans are available. 
Although the OEC has been the subject of extensive 
experimental work at high altitude over the past half 
century, many of the results are of limited value because 
the effect of red cell 2,3-DPG concentration has been 
appreciated only recently (2, 4). This compound has a 
profound effect on hemoglobin-O2 affinity, but since its 
concentration rapidly decreases in vitro, it must be mea- 
sured within a few hours of blood collection. Obviously, 
immediate measurement is difficult in mountainous re- 
mote areas of the world. 
The American Medical Research Expedition to Ever- 
est (AMREE, 1981) afforded a unique opportunity to 
study the red cell response and OEC at extreme altitude 
in 20 climbers and scientists. Our recent observations in 
the South American Andes indicated that sophisticated 
hematologic and acid-base measurements were possible, 
even under primitive circumstances (27). In addition, we 
had recently developed new instruments for field use 
that made measurements of 2,3-DPG, P50 (the POT at 
which hemoglobin is 50% saturated), blood gases, and 
hematologic parameters possible, without the need to 
transport blood samples over long distances or time (15- 
18). This report summarizes the studies on Mt. Everest. 
METHODS 
Subjects. All AMREE members were males whose ages 
ranged from 26 to 52 yr old. The degree of physical 
training and climbing experience varied somewhat 
among the members of the group. Before the beginning 
of the expedition, all members were informed fully of the 
nature of the experiments and the risks of venipuncture; 
all consented to participate. 
Laboratories and equipment. Studies were conducted 
in three principal locations: 1) San Diego, California 
(May 1981), 2) Base Camp (Sept 1981), and 3) Camp II 
(middle and late Ott, 1981). The locations and elevations 
of these sites are shown diagramatically in Fig. 1. Care 
was taken to use the same techniques, instruments, and 
reagent stocks in each of the three locations. Instruments 
were packed and transported in special lightweight con- 
tainers and carried at various times by ship, truck, plane, 
backpack, and yak. The laboratory huts and logistics of 
the expedition have been described by West (24). Blood 
gas and P50 measurements were not made at Base Camp 
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because the pH meter and a tonometer unit were dam- 
aged; they were repaired only in time for the Camp II 
studies. 
Hematologic measurements. All venous blood samples 
were taken without stasis using plastic syringes with no. 
20 needles. The anticoagulant we used was heparin that 
contained enough NaF to provide a final blood concen- 
tration of about 1 pmol/ml. This concentration of NaF 
effectively inhibits glycolysis in whole blood (unpub- 
lished observations). The samples were immediately 
placed on ice where they were kept until use. 
Hematocrit measurements were made using a battery- 
powered Compur Ml 100 minicentrifuge. This instru- 
ment has a radius of centrifugation of 3.46 cm and a 
speed of 11,500 rpm. Each centrifugation cycle was 3 
min, 20 s. The samples were subjected to repeated cen- 
trifugation cycles until the reading was constant. 
Total hemoglobin concentration was determined in 
two ways. In San Diego and at Base Camp, 20 ~1 of whole 
blood were added to 5 ml of Drabkin’s solution (Fisher 
Scientific) containing 0.1% Sterox. After 20 min, the 
absorbance at 540 nm was determined with a Perkin- 
Elmer model 35 spectrophotometer. A standard curve 
was prepared using various dilutions of International 
Standard hemoglobin solution no. 90500 from the Inter- 
national Committee for Standardization in Hematology, 
World Health Organization, kindly supplied by Dr. 0. 
van Assendelft, Centers for Disease Control. Alterna- 
tively, hemoglobin concentration was measured using a 
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battery-powered Compur Ml000 miniphotometer and 
the reagents supplied by the manufacturer. No difference 
in results could be detected by the two methods. 
As a separate check of the hemoglobin measurements, 
13 samples were drawn at Base Camp at the end of the 
expedition; hemoglobin concentration was measured and 
the samples were returned to Atlanta where the concen- 
trations were measured using a Ljungberg hemometer. 
Red blood cell counts were made with the Compur 
Ml000 miniphotometer and the reagent kits supplied by 
the manufacturer. The above instrument measures the 
turbidity of a cell suspension; no effort was made to 
verify its accuracy. Both of the Compur instruments have 
been evaluated previously (7). 
2,3-DPG. Measurements of red cell 2,3-DPG were 
made using kits from Boehringer-Mannheim (catalog no. 
148334). These kits were packed in dry ice and hand- 
carried in insulated cartons to Katmandu and then by 
backpack to Base Camp. After the reagents were recon- 
stituted, they were kept at ice temperature. The manu- 
facturer’s instruments for outdating the solutions were 
followed. Plastic disposable glassware was used through- 
out the procedures. Gilson micropipettors and tips were 
used to measure all reagents. Results are expressed as 
the [2,3-DPG]/[Hb] molar ratio. 
At sea level, Base Camp, and Camp II, protein-free 
extracts were made within minutes of venipuncture, ac- 
cording to the manufacturer’s instructions. The extracts 
were neutralized and stored on ice. Control experiments 
at Base Camp confirmed that the extracts were stable 
for up to 5 days. Extracts made at Camp II were carried 
through the Khumbu icefall to Base Camp in a Dewar 
flask containing an ice-water slurry, usually on the day 
after preparation; the delay was never longer than 2 days. 
The 2,3-DPG assays were carried out at Base Camp on 
the day of receipt. 
Blood gases and acid-base status. Blood gas and acid- 
base measurements were made at sea level and Camp II 
using the same instruments, electrodes, and standards. 
The instrument was an Instrumentation Laboratories 
(Lexington, MA) model 213 blood gas apparatus fitted 
with Instrumentation Laboratories POT, Pco~, and pH 
electrodes. Instrumentation Laboratories electrolytes 
and buffers were used throughout. Calibration mixtures 
of 02, C02, and N, were obtained from Lif-0-Gen (Cam- 
bridge, MD), and their compositions were specified to a 
nominal to.02 %. 
Arterial blood was drawn at Camp II from radial 
arteries in three volunteers breathing either ambient air 
or a hypoxic mixture. The heparin-NaF anticoagulant 
described above was used, and the measurements were 
made immediately. Base excess was calculated using the 
algorithms of Thomas (21), modified to accept the O2 
saturation values. 
Tonometry flasks. Tonometry flasks were filled within 
3 days of use; they were filled at Base Camp for mea- 
surements at Camp II. These flasks, described in detail 
elsewhere (16), were sealed with rubber injection stop- 
pers. Two no. 25 needles were used to introduce the gas, 
which was flowing at 250 ml/min for 10 min. The outflow 
was connected to a length of tubing submerged in HZ0 
to a level to insure that, at the end of the procedure, the 
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pressure in the flask exceeded ambient pressure by 20 
cmH20. Later, the pressures were equalized by allowing 
some gas to escape when injecting the blood. 
RESULTS 
Hemoglobin saturation. We measured hemoglobin-02 
saturation using an instrument constructed by Advanced 
Products (SRL, Milan, Italy) that is described separately 
(17). This consisted of a closed l-ml cuvette containing 
0.01% sodium borate, pH 9.1, 0.1% Sterox, and a small 
amount of antifoaming agent in equilibrium with air. An 
O2 electrode with Instrumentation Laboratories electro- 
lyte was in contact with the buffer. Lysis of the cells 
occurs when a sample of blood (10 ~1) is introduced into 
the buffer. Because of dilution and the very high pH, 
hemoglobin becomes saturated with 02, and the observed 
drop in Pas corresponds to the amount of deoxy hemo- 
globin present in the sample. After noting this drop, we 
added 5 ~1 K3Fe(CN)s to oxidize the hemoglobin and 
release all bound OZ. The rise in POT corresponds to total 
0, capacity, and the ratio initial drop/total rise is frac- 
tional saturation. 
Figure 1 shows, diagramatically, the locations and 
altitudes of our various activities. The transportation of 
red cell extracts down the Khumbu icefall between Camp 
II and Base Camp was a continuous problem because of 
limited personnel and weather uncertainty. Personal dis- 
comfort was considerable, particularly during the first 2 
wk at Base Camp and the month at Camp II, but none 
of the operations or procedures was unreasonably diffi- 
cult. Results of the programmed calculation of the satu- 
ration 0, and Pso results were extremely useful in mon- 
itoring results as data were taken. 
P,o measurements. Blood PsO measurements were made 
according to the general method described previously 
(15). Oxygenated fresh blood (250 ~1) was injected into a 
tonometry flask that had been filled with gas mixtures 
of known O2 and CO2 composition to approximate the 
anticipated PFiO and arterial Pco~. The samples were 
equilibrated with the gases in a tonometer for 20 min at 
37°C. 
The tonometer was modified from that previously de- 
scribed (17); the heater block was removed from its 
housing and placed into a Styrofoam container for better 
insulation. The temperature of the blood was measured 
after each equilibration with a thermister probe (Yellow 
Springs Instrument, Yellow Springs, OH), kindly sup- 
plied by the manufacturer; it was specially calibrated by 
the factory before the expedition. 
Hematocrit and hemoglobin. Table 1 lists the values 
for hemoglobin, hematocrit, and mean corpuscular hemo- 
globin concentration at the various locations. As ex- 
pected, hematocrit and hemog!obin concentration in- 
creased over the period of exposure to altitude. Never- 
theless, the hematocrit values were somewhat lower than 
those reported in previous studies at similar altitudes (3, 
14). In anticipation of such problems, our methods were 
standardized before and after the expedition. The hem- 
atocrit minicentrifuge, with battery power, was evaluated 
at the Centers for Disease Control with conventional 
methods and was found to be accurate. In addition, 
samples from Base Camp were returned to the United 
States, and measurements were made using conventional 
methods; these studies confirmed the accuracy of the 
method (Fig. 2). 
In general, persons whose hematocrits were in the 
lower part of the normal range at sea level remained in 
the lower range as altitude increased (Fig. 3). No corre- 
lation between absolute hematocrit, or relative change, 
and performance in climbing or success in acclimitization 
was noted within the group. 
Since the PO, is chosen close to Pso, a logarithmic form 
of the Hill equation 
log (Y/l - Y) = n log PO2 + C (1) 
can be used to extrapolate to PsO. The slope, n = 2.62, 
corresponds to a 2,3-DPG/Hb ratio of 1.25 (16); slight 
variations in 2,3-DPG have little effect on this value 
(16). All of the calculations pertaining to saturation, PO*, 
Pco~, and Pso are discussed in detail in previous publi- 
cations (16, 17) and were performed on a Texas Instru- 
ments SR-62 pocket calculator. 
Mean corpuscular hemoglobin concentration. Mean cor- 
puscular hemoglobin concentration (MCHC) increased 
in all members (Fig. 4). As with hematocrit, the increases 
were parallel and may reflect red cell dehydration, but 
other data related to hemoconcentration would be re- 
quired to be certain. 
Blood tonometry and acid-base status. Acid-base status 
was estimated or measured at several altitudes using the 
algorithms of Thomas (21); it was assumed that plasma 
protein changes did not affect the blood buffer base and 
that body temperature was 37°C in all cases. These 
algorithms allow consideration of the effect of hemoglo- 
bin saturation on the calculation of base excess. In all 
TABLE 1. Mean hematologic and acid-base measurements 
Altitude HB, 
g/d1 
Hct, 
% 
MCHC, 
g/d1 
2,3-DPG, 
mol/mol 
PH 
PC&, 
Torr 
Tonometry 
[ HCOs], 
n-w/l 
BE, 
medl 
P 50, 
Torr 
__~- ..- 
Sea level 14.5 t, 0.7 43.8 t 2.3 33.2 t 1.0 0.84 k 0.12 7.399 t 0.017 41.9 25.2 l.k 1.0 -0.3 t 1.22 28.1 * 1.1 
(18) (18) (18) (18) (17) (17) (17) (17) (18) 
5,400 m 17.8 t 1.0 50.8 k 2.6 35.1 k 1.4 1.05 t 0.09 
(20) (20) (20) (19) 
6,300 m 18.8 t 1.5 53.4 t_ 4.0 35.2 t, 1.1 1.04 t, 0.12 7.413 k 0.034 22.6 14.1 t, 1.2 -8.7 t 1.7 29.8 t_ 2.2 
(19) (18) (18) (17) (14) (14) (14) (14) 
Values are means IL SD for no. of measurements given in parentheses. Hb, hemoglobin; Hct, hematocrit; MCHC, mean corpuscular hemoglobin 
concentration; 2,3-DPG, 2,3-disphosphoglycerate; pC02, CO, partial partial; BE, base excess; P50, POT at which hemoglobin is 50% saturated. 
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FIG. 2. Hemoglobin concentration. Fresh blood was drawn at Base 
Camp from 13 volunteers. Hemoglobin concentration was measured 
immediately using the Compur minispectrophotometer. These samples 
were then returned to Atlanta and measured again using the Ljungberg 
Hemomometer. Lines of identity are shown; r = 0.982. 
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FIG. 3. Hematocrit values at various altitudes. 
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cases, our calculations were conducted using the mea- 
sured saturation after tonometry. 
At sea level, the mean pH of equilibrated blood was 
7.399 at PCO~ 41.9 Torr and hematocrit 43.8; this corre- 
sponds to a mean base excess of -0.3 meq/l, a value 
which is within the error of the methods. Since the same 
techniques were used throughout our work, comparisons 
should be valid. 
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FIG. 4. Mean corpuscular hemoglobin concentration (MCHC) val- 
ues at various altitudes. 
At Camp II, the mean base excess (n = 14) was -8.7 
t 1.7 meq/l measured by tonometry. In three subjects, 
arterial blood was sampled and base excess was calcu- 
lated from direct measurement of pH, Pco~, and satu- 
ration, and after tonometry of the same samples (Table 
2). The two methods gave similar results; base excess 
values were -6.7 meq/l for tonometry and -7.9 meq/l 
for the direct blood gas, pH, and saturation methods. 
Blood drawn on the South Co1 from two subjects 
returning from the summit was subjected to the tonom- 
etry technique (Table 3). Their mean in vitro base excess 
was -7.2 meq/l, a value close to the mean for the Camp 
II group as a whole. It appears that compensation for 
respiratory alkalosis for one of these subjects (CP) was 
less effective than it had been earlier. On Oct. 8, his base 
excess of Camp II was -9.8 meq/l, whereas on the day 
after reaching the summit (Ott 25) his base excess was 
-5.9 meq/l (Table 3). 
In vivo acid-base status on summit. Since direct sam- 
pling of arterial blood on the South Co1 or summit was 
not possible, in vivo pH must be inferred from the 
tonometry data. This was accomplished as follows. Ve- 
nous blood was sampled from two climbers on the South 
Co1 (Table 3) about 12 h after returning from the summit. 
The samples were taken to Camp II and equilibrated to 
a final PCO~ of 22.6 Torr. The pH was measured, and BE 
was calculated using the Thomas algorithms (21). To 
estimate the summit pH, in one of the climbers (Table 
4) we then used the alveolar PCO~ measured on the 
summit (7.5 Torr, Ref. 25) and assumed arterial PCO~ = 
alveolar Pco~. To construct an in vivo buffer line on the 
Sigaard-Anderson alignment nomogram (20), we reduced 
the hemoglobin concentration by one-third (19) and ex- 
trapolated to a summit pH of approximately 7.78. 
Our figures predict that, for complete metabolic com- 
pensation on the summit, base excess would have to be 
about -18 meq/l (for blood pH of 7.4). Thus, blood pH 
is substantially higher than was predicted before the 
expedition (26). This has important consequences for the 
interpretation of 02 transport because of its effect on the 
OEC, as discussed below (DISCUSSION). 
RED CELL FUNCTION ON MT. EVEREST 113 
TABLE 2. Arterial blood measurements 
at Camp II (6,300 m) 
Subj No. Gas PH 
pco2, PO*, 
Torr 
Sat BE, ~~~~~- 
Torr Fraction meq/l meq/mi 
1 Ambient 7.467 19.9 40.0 0.666 -7.2 -6.8 
Hypoxic 7.508 
2 Ambient 7.484 19.6 38.0 0.734 -6.8 -6.2 
Hypoxic 7.500 19.4 29.9 0.578 -6.5 
3 Ambient 7.455 15.8 39.3 0.762 -9.3 -7.2 
Hypoxic 7.533 14.0 25.0 0.457 -8.5 
Mean Ambient 7.467 18.4 39.1 0.721 -7.9 -6.7 
Hypoxic 7.514 16.8 27.4 0.5 18 -7.5 
PC02, COz partial pressure; PO*, O2 partial pressure; Sat, saturation; 
BE, base excess. 
TABLE 3. Blood from two returning 
summiters taken at 8,OfsO m 
Variable Subj PH Subj CP 
Measured values 
Hb, g/dl 
Hct, % 
RBC x lo-“/fl 
2,3-DPG, [DPG]/[Hb] 
PACT,, Torr” 
PAN,, Torr* 
R* 
Blood tonometry 
Pco~, Torr 
PO,, Torr 
PH 
Saturation, fraction 
BE, meq/l 
(HCO;), meq/l 
Calculated values, South Co1 
MCHC, g/d1 
MCH, pg/cell 
MCV, fl 
pH, in vivot 
pso, 7.4 
P50, in vivo 
18.0 18.7 
50.0 54.0 
6.40 6.55 
1.20 1.12 
13.3 12.5 
31.4 36.3 
0.67 0.91 
22.6 22.6 
36.6 37.7 
7.425 7.460 
0.597 0.720 
-8.4 -5.9 
14.4 15.6 
36.0 34.6 
28.1 28.5 
78.1 82.4 
7.520 7.585 
31.8 27.4 
27.7 22.1 
RBC, red blood cell; PACT,, alveolar Pco~; PAN,, alveolar Paz; R, 
respiratory exchange ratio; MCH, mean corpuscular hemoglobin; MCV, 
mean corpuscular volume. See Table 1 for additional abbreviations. 
* See Ref. 25. t Assume Pace, = PACT,. 
&. Blood PFiO values at sea level and Camp II are 
given in Table 1. The values have been adjusted to pH 
7.4 using a Bohr factor of -0.45, corresponding to a 2,3- 
DPG/Hb ratio of 1.25 (18). As a check of these values, 
the P&s estimated from our previous work relating 2,3- 
DPG, pH, and PCO~ (28) are 28.3 Torr at sea level and 
29.4 Torr at Camp II, compared with mean measured 
values of 28.1 and 29.8 Torr. Thus the P50 is completely 
accounted for by the known effecters of red cell oxygen 
affinity (2,3-DPG, pH, and Pco~); no additional factors 
need be postulated. 
The PsO values for the South Co1 blood cannot be taken 
as representative of the group as a whole, because only 
two samples were studied. However, PsO increased in CP 
between Camp II and the South Col; 2,3-DPG also in- 
creased, whereas in pH, the difference was within the 
limits of the error found in sea level control experiments 
(to.08 mol/mol) (27). 
Alveolar gas was measured on the summit in only one 
climber (CP). The data and calculations therefrom are 
given in Table 4. To calculate the summit P50 in this 
subject, we used an in vivo blood pH of 7.78. The subjects 
PsO at pH 7.4 was 27.6 Torr; if the Bohr factor was -0.45, 
the PsO on the summit would have been 19.4 Torr. 
Table 5 and Fig. 5 summarize the P50 measurements. 
The PsO at pH 7.4 increases with increasing 2,3-DPG up 
to 6,300 m, but then decreases slightly, even though 2,3- 
DPG increases further. This may be explained by the 
lower PCO~ at which measurements were made at 6,300 
m compared with sea level and the small number of 
observations above 6,300 m. However, a precise descrip- 
tion of the effect of very low PCO~ on the whole blood 
OEC is still lacking (28). 
DISCUSSION 
Hemoglobin and hematocrit. Two previous expeditions 
to similar altitudes reported hematologic data in suffi- 
cient numbers to permit detailed comparisons (3, 14); 
this is shown in Table 6. Using a t test for small samples, 
we found that our red cell counts at 6,300 m were not 
different from those in 1973. Our hemoglobin and hem- 
atocrit values were slightly different from those in 1960- 
61 (P = 0.025) but clearly different from those in 1973 
(P c 0.005). 
Of the measurements compared, hemoglobin concen- 
tration should be the simplest to verify. Unfortunately 
we were not given the details of the methods for blood 
collection or measurements in the previous studies. In 
the 1960-61 expedition, a subsample (n = 6) of subjects 
in whom red cell mass was measured had a mean hemo- 
globin concentration of 19.1 g/d1 (14). These data were 
from estimates of CO capacity, measured volumetrically. 
In 1973, the mean hemoglobin concentration for 10 sub- 
TABLE 4. Measurements taken at summit 
Subj CP 
Measured values 
PACT,, Torr* 
PAN,, Torr” 
BE, meq/l (from South Col) 
Calculated values 
Pao,, Torr* 
PsO, pH 7.4, Torr 
pH, in vivo 
PsO in vivo, Torr 
7.5 
35 
-5.9 
28 
27.4 
7.78 
19.4 
Pao,, arterial Po2. See Tables 1 and 3 for additional abbreviations. 
* See Ref. 25. 
TABLE 5. Blood O2 affinity 
Location pH n PPGI/ Paco2, Pe,, ho 7.4, 2;” v-w Torr Torr Torr Tar; 
Sa 
02 
Sea level 7.399 18 0.84 40 90 28.1 28.1 0.95 
6,300 m 7.467” 14 1.04 18.4t 39.1 t 29.8 27.6 0.71 
8,050 m 7.552 2 1.18 12.8 29.6 24.9 
8,848 m 7.78 1 7.5 28t 27.4 19.4 0.72 -__- 
[DPG]/[Hb], 2,3-diphosphoglycerate acid-to-hemoglobin concentra- 
tion ratio; Paco2, arterial Pco*; Pao2, arterial Po2; PsO, Po2 at which 
hemoglobin is 50% saturated; Sao2, saturation of hemoglobin with O2 
in arterial blood. * Arterial measurements, Table 2. t See Ref. 
25. 
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FIG. 5. Effecters of blood O2 affinity. Data are from Table 5. In- 
creasing blood pH (pHb) decreases PO;! at which hemoglobin is 50% 
saturated (P&. Net result (bottom panel) is that arterial 02 saturation 
is protected at extreme altitude. Pao,, arterial POT; Pace,, arterial Pco~; 
DPG, 2,3-diphosphoglycerate. 
TABLE 6. Hematologic findings at extreme altitude 
Alti- 
Yr tude, 
m 
1960-61 5,790 
1973 5,350 
1981 5,400 
6,300 
Hh Hct, RBC, 
g/d1 % x 10-y fl 
19.6tl.O 55.8t3.3 5.60t0.43 
(24) (21) (18) 
20.61kO.4 63.8k4.6 6.57k0.68 
(10) (10) (10) 
17.821.0 50.8t2.6 
(20) (2% 
18.8& 1.5 53.4k4.0 6.61t0.40 
(19) UN Of9 
99.6 35.0 35.1 14 
97.1 31.4 32.3 2 
80.8 28.4 35.2 
Values are means t SD for no. of measurements given in parenthe- 
ses. See Tables 1 and 3 for definitions. 
jects at 5,350 m was 20.6 g/dl. These measurements were 
by the cyanomethemoglobin method, but the instru- 
ments, standards, and method of blood collection and 
storage were not given in the report (3) and some of the 
subjects had resided at altitudes greater than 5,000 m for 
extended periods of time (P. Cerretelli, personal com- 
munication). 
Hematocrit, although more directly related to blood 
viscosity than hemoglobin concentration, is more diffi- 
cult to measure accurately and even more difficult to 
verify. High hematocrits require longer centrifugation 
times and higher relative centrifugal fields (RCF). The 
National Committee for Clinical and Laboratory Stand- 
ards (NCCLS) (14) defines the RCF 
RCF = 1.18 X 10D5 X r X n2 (2) 
where r is the rotating radius (cm) and n is the rotating 
speed (rpm). For our centrifuge, RCF = 5,400. According 
to Pugh (14), their centrifuge had a radius of 10 cm and 
operated at 3,000 rpm; hence, RCF = 1,062. The centri- 
fuge used in 1973 (3) operated at 3,500 rpm but the 
rotating radius is not given. In addition to these consid- 
erations, the NCCLS recommends that, when hemato- 
crits are greater than 50%, RCF at the top of the blood 
column should be greater than 3,000. It is also essential 
to subject the samples to repeated centrifugations to 
verify that the hematocrit is minimal. It is possible, 
therefore, that neither of the two previous methods pro- 
vided a sufficient centrifugal field to properly pack the 
cells. 
Another suggestion that the 1973 hematocrits were too 
high comes from the distinctly low MCHC’s found. Our 
data and those from 1960-61 agree quite well (35.2 g/d1 
and 35.1 g/dl), whereas the 1973 data are unusually low 
(32.3 g/dl). Since the MCHC is the ratio of hemoglobin 
concentration to hematocrit, this seems best explained 
by a spuriously high hematocrit. 
Mean corpuscular hemoglobin concentration. In spite 
of their concerted efforts to take in large amounts of 
liquid, MCHC increased in all expedition members. Since 
the flow properties of red cells are dependent, to some 
extent, on MCHC, understanding of this point could be 
of practical and theoretical importance. Unfortunately, 
we do not know whether red cell dehydration results 
from body dehydration or from some abnormality of red 
cell water transport. For example, it is known that 2,3- 
DPG influences the Donnan equilibrium of the red cell 
membrane to alter the relation between intracellular and 
extracellular pH (18). Changes in pH can affect red cell 
volume in vitro (29), but in vivo effects have not been 
demonstrated (1). This problem is in need of further 
study. 
Hemoglobin saturation. A potential difficulty in the 
method at extreme altitude may be a lack of sufficient 
O2 dissolved in the borate buffer to completely oxygenate 
the hemoglobin when a sample is introduced; that this 
was not the case can be calculated as follows. If the 
cuvette volume is 1 ml, temperature is 25°C barometric 
pressure is 350 Torr, and the solubility of 0, in the 
borate buffer is 1.49 x 10m6 mol. 1-l l Torr-’ (15), the total 
O2 in the cuvette would be 1.09 x low7 mol. If hemoglobin 
is half-saturated with 02 and its concentration is 20 g/ 
dl, 0.62 x 10m7 mol of O2 would be required for conversion 
of deoxy to oxyhemoglobin. Thus a twofold excess 02 
was present; this is the worst case, because the hemoglo- 
bin concentration was usually less than 20 g/dl, and the 
temperature usually less than 25°C (thereby increasing 
O2 solubility). In fact, after addition of hemoglobin to 
the borate buffer, the mean Poft was 52.0 Torr (range 
45.5 - 58.3 Torr) for 21 determinations at Camp II. For 
the same 21 samples, the mean measured 02 saturation 
was 0.646 range 0.555 - 0.736). Since hemoglobin can be 
assumed to be 100% saturated with 0, at a POT of 30 
RED CELL FUNCTION ON MT. EVEREST 115 
Torr in the borate buffer (15), our measurements are 
accurate, even at Camp II. 
Blood 02 equilibrium curue. Shifts in the position and 
shape in the blood OEC have intrigued physiologists and 
biochemists for many years because of the implications 
for 0, transport and for adaptation to high altitude. 
Measurements made primarily in Andes of South Amer- 
ica suggested that the OEC shifts to the right, thereby 
augmenting release of 02 to tissues (10). Most previous 
results, however, were made under standard conditions 
of pH and Pco~, and it has been appreciated only recently 
that, because of incomplete compensation for respiratory 
alkalosis, in vivo P,, up to 4,250 m is very close to that 
found at sea level (27). 
The importance of the red cell glycolytic intermediate, 
2,3-DPG, was first appreciated in 1967 (2, 4). This com- 
pound has a strong influence on the oxygenation prop- 
erties of hemoglobin; it shifts the OEC to the right, a 
potentially important mechanism for increasing O2 sup- 
ply to tissues during anemia. The discovery was impor- 
tant for high altitude work, not only because of this effect 
on 
in 
the OEC, but also because it is quickly metabolized 
vitro and therefore must be measured in fresh blood 
samples. Much data from high altitude expeditions must 
be disregarded because 2,3-DPG was not measured or 
because samples were not studied while fresh. 
A second problem with studies of the blood OEC at 
high altitude is that many measurements have been made 
under standard conditions; in vivo pH and PCO~ have 
usually not been considered. A P50 value at pH 7.4, PCO~ 
= 40 Torr has little relevance for a climber whose PCO* 
may be 7.5 Torr and pH nearly 7.8, as in the case of the 
present study. Before AMREE, no good data were avail- 
able on arterial conditions at extreme altitude. The stud- 
ies of Weiskopf and Severinghaus (23) also demonstrated 
a respiratory alkalosis, but they did not measure 2,3- 
DPG. 
We have tried to measure all of the physiologic param- 
eters of P.50. In a previous study, we measured P50 and 
2,3-DPG in a large number of natives of the Peruvian 
Andes (27). These measurements, coupled with in vivo 
pH and Pco~, allowed us to conclude [as did Weiskopf 
and Severinghaus (23)] that a small right shift of the 
OEC, due to increased 2,3-DPG, is offset, in vivo, by a 
left shift, due to respiratory alkalosis. The net result was 
that in vivo P 50 was indistinguishable from sea-level 
controls. 
Blood PH. We previously reported that polycythemia 
decreases the apparent blood pH at consta nt plasma pH 
(27 ). The mechanism of the effect is not understood, but 
we believe the most reliable pH would be that of plasma. 
However, existing nomograms and computer algorithms 
for blood acid-base and gas calculations use blood pH 
measured at unspecified hematocrits. Recognizing these 
limitations, we have reported blood pH values in Tables 
l-6. Any error introduced by hematocrit would, however, 
be small, since the hematocrits found in our subjects did 
not increase to the levels reported previously for Andean 
natives. For example, using formulas 2 and 3 of reference 
27, the mean pH at Camp II of 7.413 would increase only 
0.008 pH units if it were corrected to hematocrit 45%. 
Z,3-DPG. Concentration of 2,3-DPG within the red 
cell is believed to be under the general control of pH 
(12). In our studies, pH increased strikingly above 6,300 
m but with little additional increase in 2,3-DPG. Perhaps 
mean pH is not really increased; it may fall in exercise 
or during sleep. 
Acid-base balance. We found that respiratory alkalosis 
is never completely compensated. This finding is in 
agreement with previous observations in Andean natives 
at 4,250 m (11, 27) or in Sherpas at similar altitude (11). 
Sojourners also do not compensate, even after several 
weeks of acclimatization (11). This failure of blood pH 
to return to sea-level values is still not understood. 
Estimations of in vivo base e xcess and, even more, 
arterial plasma pH, are subject to co nsiderable uncer- 
tainty arising from several sources. First, most nomo- 
grams are most accurate around normal conditions (21); 
the summit conditions are extreme. Second, the nomo- 
grams were constructed assuming blood and plasma pH 
are equivalent; polycythemia has not been accounted for. 
Third, the buffering effect of plasma has not been cal- 
culated in our studies. Increased MCHC suggests dehy- 
dration, which would increase plasma protein concentra- 
tion. Finally, the in vivo ~H-Pco~ relationship is well 
known to differ from that found in vitro (19). 
In spite of the above limitations and qualifications, 
our data indicate that PsO is maintained over a very 
narrow range up to an altitude of 6,300 m. This mainte- 
nance is due to the opposing effects of 2,3-DPG and pH 
(the Bohr effect). Above 6,300 m, the OEC shifts pro- 
gressively to the left, due to the stronger effect of alka- 
losis. The various effecters of the OEC are shown in 
summary in Fig. 5. Although the estimates of in vivo pH 
are approximations, the clear rise above 6,300 m will 
certainly mean that arterial 02 saturation will be pro- 
tected. Regardless of the mechanism of the extreme 
alkalosis, it 
Climbers 
does 
usua 
appear to be beneficial. 
lly elect to acclimatize for 1 or 2 days 
below the summit, then attempt the summit in sudden 
pushes. The progressive shift to the left of the OEC 
above Camp II suggests that this intuitive climbing strat- 
egy might be a good one; a left shift could confer some 
advantage because arterial saturation increases. Indeed, 
experimental animals survive better at extreme altitude 
when the OEC is left shifted (5), and persons with mutant 
hemoglobins with high 0, affinity apparently acclimatize 
more efficiently at moderate altitude than their normal 
counterparts (9). 
All members of the American Medical Research Expedition to 
Everest were active participants in this study. In addition, we are 
deeply indebted to the Nepali porters and Sherpas who transported 
much of the equipment and supplies with extreme care at great personal 
risk; they too, were indispensable participants. We are indebted also to 
Dr. I. Raffaele, Advanced Products, Milan, Italy, for the prototype of 
the Oxyan-2 and tonometer, and to H. Trolander, Yellow Springs 
Instrument, Yellow Springs, OH, for the thermometer and calibrated 
probes. Finally, we are especially grateful to John Evans, climbing 
leader, for the overall safety and success of the climbing expedition, 
without whom no studies would have been possible. 
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